Details of the Drug
General Information of Drug (ID: DM0EBWR)
Drug Name |
5-{8(Z),11(Z)-pentadecadienyl}resorcinol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
5-{8(Z),11(Z)-pentadecadienyl}resorcinol; CHEMBL459604; 5-(8,11-Pentadecadienyl)-1,3-benzenediol; 5-[(8Z,11Z)-pentadeca-8,11-dien-1-yl]benzene-1,3-diol; Cardoldiene; 5-((8Z,11Z)-pentadeca-8,11-dien-1-yl)benzene-1,3-diol; SCHEMBL9475761; DTXSID70872872; MolPort-005-944-663; 79473-25-9; ZINC31157863; LMPK15030021; BDBM50292428; AKOS030555484; MCULE-2398296746; RESORCINOL(15:2(8Z,11Z)); 5-(pentadeca-8,11-dienyl)benzene-1,3-diol; 5-((8Z,11Z)-pentadeca-8,11-dien-1-yl)resorcinol
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 316.5 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 7.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 12 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||